Open an account

CVS Health

CVS · NYSE

$94.75+$2.07 (+2.23%)TodayMarket closed ·
Prev close $92.68

About CVS

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

Employees
300,000
Headquarters
Woonsocket, Rhode Island
Listed
Oct 1, 1952
Sector
Health Care
Industry
Health Care Providers & Services
Website
cvshealth.com

CVS key statistics

Market cap
118.53B
Price-earnings ratio
24.39
Dividend yield
2.90%
Average volume
9.54M
Volume
4.96M
Open price
$93.26
High today
$94.91
Low today
$93.20
52 Week high
$110.68
52 Week low
$69.51

CVS Health (CVS) at a glance

As of Oct 20, 2026, CVS Health (CVS) shares are priced at $94.75, giving the company a market cap of 118.53B, a price-to-earnings ratio of 24.39 and a dividend yield of 2.90%.

Today the stock has traded between $93.20 and $94.91. The current price is 1.7% above the day's low and 0.2% below its high.

Volume so far is 4.96M shares, below the average of 9.54M shares a day.

Over the past year CVS Health has ranged from $69.51 to $110.68, and now sits 61% of the way up that range.

CVS Health met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $2.58 per share against an estimate of $1.87.

The average analyst price target is $115.19, 21.6% above the current price, from 17 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 17 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 28 analystsAvg $115.19
Low
$79.79
Now
$94.75
High
$131.25

CVS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 22.8% on average.

  1. Q3 FY24: reported $1.09 per share against an estimate of $1.52
  2. Q4 FY24: reported $1.19 per share against an estimate of $0.9351
  3. Q1 FY25: reported $2.25 per share against an estimate of $1.72
  4. Q2 FY25: reported $1.81 per share against an estimate of $1.47
  5. Q3 FY25: reported $1.60 per share against an estimate of $1.38
  6. Q4 FY25: reported $1.09 per share against an estimate of $1.00
  7. Q1 FY26: reported $2.57 per share against an estimate of $2.22
  8. Q2 FY26: reported $2.58 per share against an estimate of $1.87

CVS news

  • Press releasePRNewswire

    MinuteClinic® opens three new retail medical clinics to serve Massachusetts patients

  • Press releaseGlobe Newswire

    The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

  • Press releasePRNewswire

    CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey

  • Press releasePRNewswire

    MinuteClinic earns seventh consecutive Joint Commission accreditation, including first evaluation under Medical Center standards

  • Vandana Singh

    CVS Agrees to $315 Million Settlement Over Alleged Illegal Opioid Prescriptions

  • Erica Kollmann

    QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins

  • Press releasePRNewswire

    Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releasePRNewswire

    CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.